» Articles » PMID: 20095832

CCL3L1 Copy Number is a Strong Genetic Determinant of HIV Seropositivity in Caucasian Intravenous Drug Users

Overview
Journal J Infect Dis
Date 2010 Jan 26
PMID 20095832
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A high copy number of CCL3L1, the most potent human immunodeficiency virus (HIV)-suppressive chemokine, associates with reduced HIV susceptibility. Whether CCL3L1 influences acquisition of multiple blood-borne infections (eg, hepatitis C virus [HCV], HIV, and hepatitis B virus [HBV] infections), which occur commonly among injection drug users (IDUs), is unknown.

Methods: We determined CCL3L1 copy number by real-time polymerase chain reaction among 374 Caucasian IDUs from Estonia; 285 were HCV positive, 208 were HIV positive, 177 were HCV and HIV positive, and 57 were HCV and HIV negative.

Results: In univariate and multivariate analyses, HCV and HBV seropositivity and duration of IDU each strongly predicted HIV seropositivity. A high CCL3L1 copy number (>2) was associated with an 80% reduced risk of acquiring HIV infection after adjusting for age, sex, HCV and HBV status, CCR5-Delta32 polymorphism, and IDU duration (odds ratio, 0.20; 95% confidence interval, 0.09-0.45). By contrast, CCL3L1 gene dose did not influence HCV seropositivity. Among HCV-positive IDUs, there was a 3.5-fold overrepresentation and 65% underrepresentation of a high CCL3L1 copy number among HCV-positive, HIV-negative subjects and HCV-positive, HIV-positive subjects, respectively.

Conclusion: Among IDUs with extensive exposure to HCV and HIV, CCL3L1 copy number is a major determinant of HIV seropositivity but not of HCV seropositivity. The contrasting distribution of a protective high CCL3L1 copy number among HCV-positive, HIV-negative IDUs versus HCV-positive, HIV-positive IDUs may reflect that HIV preferentially selects for subjects with a low CCL3L1 gene dose.

Citing Articles

An atlas of immune cell transcriptomes in human immunodeficiency virus-infected immunological non-responders identified marker genes that control viral replication.

Chen Y, Li X, Liu S, Ao W, Lin J, Li Z Chin Med J (Engl). 2023; 136(22):2694-2705.

PMID: 37914674 PMC: 10684209. DOI: 10.1097/CM9.0000000000002918.


Comparative physiological anthropogeny: exploring molecular underpinnings of distinctly human phenotypes.

Vaill M, Kawanishi K, Varki N, Gagneux P, Varki A Physiol Rev. 2023; 103(3):2171-2229.

PMID: 36603157 PMC: 10151058. DOI: 10.1152/physrev.00040.2021.


Deletions in Genes Participating in Innate Immune Response Modify the Clinical Course of Andes Orthohantavirus Infection.

Ribeiro G, Leon L, Perez R, Cuiza A, Vial P, Ferres M Viruses. 2019; 11(8).

PMID: 31349540 PMC: 6723883. DOI: 10.3390/v11080680.


A CCL5 Haplotype Is Associated with Low Seropositivity Rate of HCV Infection in People Who Inject Drugs.

Huik K, Avi R, Pauskar M, Kallas E, Jogeda E, Karki T PLoS One. 2016; 11(6):e0156850.

PMID: 27304910 PMC: 4909289. DOI: 10.1371/journal.pone.0156850.


Human T-lymphotropic virus types 1 and 2 are rare among intravenous drug users in Eastern Europe.

Jogeda E, Avi R, Pauskar M, Kallas E, Karki T, Des Jarlais D Infect Genet Evol. 2016; 43:83-5.

PMID: 27223634 PMC: 4949113. DOI: 10.1016/j.meegid.2016.05.022.


References
1.
Modi W . CCL3L1 and CCL4L1 chemokine genes are located in a segmental duplication at chromosome 17q12. Genomics. 2004; 83(4):735-8. DOI: 10.1016/j.ygeno.2003.09.019. View

2.
Shankar E, Solomon S, Vignesh R, Murugavel K, Sundaram M, Solomon S . GB virus infection: a silent anti-HIV panacea within?. Trans R Soc Trop Med Hyg. 2008; 102(12):1176-80. DOI: 10.1016/j.trstmh.2008.04.034. View

3.
Lillard Jr J, Singh U, Boyaka P, Singh S, Taub D, McGhee J . MIP-1alpha and MIP-1beta differentially mediate mucosal and systemic adaptive immunity. Blood. 2002; 101(3):807-14. DOI: 10.1182/blood-2002-07-2305. View

4.
Nakajima T, Ohtani H, Naruse T, Shibata H, Mimaya J, Terunuma H . Copy number variations of CCL3L1 and long-term prognosis of HIV-1 infection in asymptomatic HIV-infected Japanese with hemophilia. Immunogenetics. 2007; 59(10):793-8. DOI: 10.1007/s00251-007-0252-4. View

5.
Shostakovich-Koretskaya L, Catano G, Chykarenko Z, He W, Gornalusse G, Mummidi S . Combinatorial content of CCL3L and CCL4L gene copy numbers influence HIV-AIDS susceptibility in Ukrainian children. AIDS. 2009; 23(6):679-88. PMC: 2929972. DOI: 10.1097/QAD.0b013e3283270b3f. View